Akshay K. Vaishnaw

2012

In 2012, Akshay K. Vaishnaw earned a total compensation of $1.2M as Executive Vice President, Research and Development and Chief Medical Officer at Alnylam Pharmaceuticals, a 8% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$175,500
Option Awards$474,795
Salary$423,275
Stock Awards$132,174
Other$6,444
Total$1,212,188

Vaishnaw received $474.8K in option awards, accounting for 39% of the total pay in 2012.

Vaishnaw also received $175.5K in non-equity incentive plan, $423.3K in salary, $132.2K in stock awards and $6.4K in other compensation.

Rankings

In 2012, Akshay K. Vaishnaw's compensation ranked 5,400th out of 11,487 executives tracked by ExecPay. In other words, Vaishnaw earned more than 53.0% of executives.

ClassificationRankingPercentile
All
5,400
out of 11,487
53rd
Division
Manufacturing
1,901
out of 4,253
55th
Major group
Chemicals And Allied Products
462
out of 1,203
62nd
Industry group
Drugs
305
out of 925
67th
Industry
Pharmaceutical Preparations
238
out of 700
66th
Source: SEC filing on March 10, 2015.

Vaishnaw's colleagues

We found four more compensation records of executives who worked with Akshay K. Vaishnaw at Alnylam Pharmaceuticals in 2012.

2012

John Maraganore

Alnylam Pharmaceuticals

Chief Executive Officer

2012

Barry Greene

Alnylam Pharmaceuticals

Chief Operating Officer

2012

Laurence Reid

Alnylam Pharmaceuticals

Senior Vice President and Chief Business Officer

2012

Michael Mason

Alnylam Pharmaceuticals

Vice President of Finance and Treasurer principal financial officer

News

You may also like